Abeona Therapeutics (ABEO) Share-based Compensation (2011 - 2026)

Abeona Therapeutics' Share-based Compensation history runs 16 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 9.48% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $11.0 million (up 41.78% YoY), while the FY2025 annual figure was $10.8 million, up 62.63% from the prior year.
• Share-based Compensation was $3.0 million for Q1 2026 at Abeona Therapeutics, up from $2.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $3.0 million in Q1 2026 to a low of $632000.0 in Q3 2022.
• Historically, Share-based Compensation has averaged $1.7 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 75.09% in 2022, then soared 146.36% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $833000.0 in 2022, then surged by 81.75% to $1.5 million in 2023, then climbed by 29.13% to $2.0 million in 2024, then surged by 30.9% to $2.6 million in 2025, then increased by 15.55% to $3.0 million in 2026.
• The last three Share-based Compensation figures came in at $3.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.